Literature DB >> 7028764

The serum-free growth of cultured cells in bovine colostrum and in milk obtained later in the lactation period.

K S Steimer, R Packard, D Holden, M Klagsbrun.   

Abstract

Seven established cell lines, including both epithelial cells and fibroblasts (MDCK, Vero, CV-1, NRK, 3T3, F2408, and NIL8) and four early passage cell strains (bovine articular chondrocytes, bovine smooth muscle cells, human foreskin fibroblasts, and rat embryo cells) were cultured in serum-free medium supplemented with milk obtained 1 day after birth (colostrum) or 80 days after birth (older milk). MDCK, Vero, CV-1, NRK, and 3T3 grew readily in colostrum and attained saturation densities ranging from 22% to 63% of that in serum. There was no growth of F2408, NIL8, or the early passage strains in bovine colostrum. None of the 11 cell cultures grew in older milk. The temporal dependence of growth in milk was examined in detail using MDCK cells. Growth equivalent to that in serum occurred in 3% colostrum and in 15% milk obtained 2 days after birth. Milk obtained 3 days and 10 days after birth was not effective as a growth supplement for MDCK cells at any concentration. Those cells, unable to grow in colostrum or in older milk, could be induced to grow if culture dishes were precoated with fibronectin. In addition to fibronectin, it was necessary in some cultures to supplement colostrum or older milk with insulin and/or transferrin in order to achieve growth. In the presence of fibronectin and appropriate factors, the final saturation density attained in colostrum or older milk ranged from 25% to 100% of that in serum. The fibronectin contents of bovine colostrum and milk were determined. The fibronectin level of colostrum was found to be approximately 5% of bovine serum. There was no detectable fibronectin in the 80-day-old milk.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028764     DOI: 10.1002/jcp.1041090205

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

Review 1.  Can milk replace serum in mammalian cell culture?

Authors:  A Electricwala
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Lipid peroxidation and activities of tyrosine aminotransferase and glutamine synthetase in hepatoma and glioma cells grown in bovine colostrum-supplemented medium.

Authors:  L Odland; S Wallin; E Walum
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

3.  Bovine colostrum is a health food supplement which prevents NSAID induced gut damage.

Authors:  R J Playford; D N Floyd; C E Macdonald; D P Calnan; R O Adenekan; W Johnson; R A Goodlad; T Marchbank
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells.

Authors:  D A Belford; M L Rogers; G O Regester; G L Francis; G W Smithers; I J Liepe; I K Priebe; F J Ballard
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

Review 5.  Bovine colostrum supplementation and exercise performance: potential mechanisms.

Authors:  Cecilia M Shing; Denise C Hunter; Lesley M Stevenson
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

6.  Bovine colostrum fraction as a serum substitute for the cultivation of mouse hybridomas.

Authors:  R Pakkanen; A Kanttinen; L Satama; J Aalto
Journal:  Appl Microbiol Biotechnol       Date:  1992-07       Impact factor: 4.813

7.  Bovine colostrum ultrafiltrate supplemented with adult bovine serum and transferrin: an effective FBS substitute for cultivation of Vero and CHO-K1 cells.

Authors:  R Pakkanen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-05       Impact factor: 2.416

8.  Establishing elements of a synthetic biology platform for Vaccinia virus production: BioBrick™ design, serum-free virus production and microcarrier-based cultivation of CV-1 cells.

Authors:  Shuchang Liu; Ludmila Ruban; Yaohe Wang; Yuhong Zhou; Darren N Nesbeth
Journal:  Heliyon       Date:  2017-02-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.